BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 12816951)

  • 1. Honokiol, a small molecular weight natural product, inhibits angiogenesis in vitro and tumor growth in vivo.
    Bai X; Cerimele F; Ushio-Fukai M; Waqas M; Campbell PM; Govindarajan B; Der CJ; Battle T; Frank DA; Ye K; Murad E; Dubiel W; Soff G; Arbiser JL
    J Biol Chem; 2003 Sep; 278(37):35501-7. PubMed ID: 12816951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liposomal honokiol, a potent anti-angiogenesis agent, in combination with radiotherapy produces a synergistic antitumor efficacy without increasing toxicity.
    Hu J; Chen LJ; Liu L; Chen X; Chen PL; Yang G; Hou WL; Tang MH; Zhang F; Wang XH; Zhao X; Wei YQ
    Exp Mol Med; 2008 Dec; 40(6):617-28. PubMed ID: 19116447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of anti-HIF and anti-angiogenic properties of honokiol for the treatment of ocular neovascular diseases.
    Vavilala DT; Ponnaluri VK; Kanjilal D; Mukherji M
    PLoS One; 2014; 9(11):e113717. PubMed ID: 25422886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-inflammatory effects of magnolol and honokiol are mediated through inhibition of the downstream pathway of MEKK-1 in NF-kappaB activation signaling.
    Lee J; Jung E; Park J; Jung K; Lee S; Hong S; Park J; Park E; Kim J; Park S; Park D
    Planta Med; 2005 Apr; 71(4):338-43. PubMed ID: 15856410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural modification of honokiol, a biphenyl occurring in Magnolia officinalis: the evaluation of honokiol analogues as inhibitors of angiogenesis and for their cytotoxicity and structure-activity relationship.
    Ma L; Chen J; Wang X; Liang X; Luo Y; Zhu W; Wang T; Peng M; Li S; Jie S; Peng A; Wei Y; Chen L
    J Med Chem; 2011 Oct; 54(19):6469-81. PubMed ID: 21853991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Shb gene knockdown increases the susceptibility of SVR endothelial tumor cells to apoptotic stimuli in vitro and in vivo.
    Funa NS; Reddy K; Bhandarkar S; Kurenova EV; Yang L; Cance WG; Welsh M; Arbiser JL
    J Invest Dermatol; 2008 Mar; 128(3):710-6. PubMed ID: 17914455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Honokiol, a natural therapeutic candidate, induces apoptosis and inhibits angiogenesis of ovarian tumor cells.
    Li Z; Liu Y; Zhao X; Pan X; Yin R; Huang C; Chen L; Wei Y
    Eur J Obstet Gynecol Reprod Biol; 2008 Sep; 140(1):95-102. PubMed ID: 18440692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Honokiol inhibits the growth of head and neck squamous cell carcinoma by targeting epidermal growth factor receptor.
    Singh T; Gupta NA; Xu S; Prasad R; Velu SE; Katiyar SK
    Oncotarget; 2015 Aug; 6(25):21268-82. PubMed ID: 26020804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Honokiol inhibits in vitro and in vivo growth of oral squamous cell carcinoma through induction of apoptosis, cell cycle arrest and autophagy.
    Huang KJ; Kuo CH; Chen SH; Lin CY; Lee YR
    J Cell Mol Med; 2018 Mar; 22(3):1894-1908. PubMed ID: 29363886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Honokiol isolated from Magnolia officinalis stimulates osteoblast function and inhibits the release of bone-resorbing mediators.
    Choi EM
    Int Immunopharmacol; 2011 Oct; 11(10):1541-5. PubMed ID: 21621646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel histone deacetylase inhibitors derived from Magnolia officinalis significantly enhance TRAIL-induced apoptosis in non-small cell lung cancer.
    Liu Y; Tong Y; Yang X; Li F; Zheng L; Liu W; Wu J; Ou R; Zhang G; Hu M; Liu Z; Lu L
    Pharmacol Res; 2016 Sep; 111():113-125. PubMed ID: 27268146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Honokiol: a promising small molecular weight natural agent for the growth inhibition of oral squamous cell carcinoma cells.
    Chen XR; Lu R; Dan HX; Liao G; Zhou M; Li XY; Ji N
    Int J Oral Sci; 2011 Jan; 3(1):34-42. PubMed ID: 21449214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Honokiol, a constituent of oriental medicinal herb magnolia officinalis, inhibits growth of PC-3 xenografts in vivo in association with apoptosis induction.
    Hahm ER; Arlotti JA; Marynowski SW; Singh SV
    Clin Cancer Res; 2008 Feb; 14(4):1248-57. PubMed ID: 18281560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery and synthesis of novel magnolol derivatives with potent anticancer activity in non-small cell lung cancer.
    Tang H; Zhang Y; Li D; Fu S; Tang M; Wan L; Chen K; Liu Z; Xue L; Peng A; Ye H; Chen L
    Eur J Med Chem; 2018 Aug; 156():190-205. PubMed ID: 30006164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Honokiol induces apoptosis and autophagy via the ROS/ERK1/2 signaling pathway in human osteosarcoma cells in vitro and in vivo.
    Huang K; Chen Y; Zhang R; Wu Y; Ma Y; Fang X; Shen S
    Cell Death Dis; 2018 Feb; 9(2):157. PubMed ID: 29410403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Honokiol inhibits vascular vessel formation of mouse embryonic stem cell-derived endothelial cells via the suppression of PECAM and MAPK/mTOR signaling pathway.
    Kim GD; Bae SY; Park HJ; Bae K; Lee SK
    Cell Physiol Biochem; 2012; 30(3):758-70. PubMed ID: 22890153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-psoriatic effects of Honokiol through the inhibition of NF-κB and VEGFR-2 in animal model of K14-VEGF transgenic mouse.
    Wen J; Wang X; Pei H; Xie C; Qiu N; Li S; Wang W; Cheng X; Chen L
    J Pharmacol Sci; 2015 Jul; 128(3):116-24. PubMed ID: 26220468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Honokiol inhibits TNF-alpha-stimulated NF-kappaB activation and NF-kappaB-regulated gene expression through suppression of IKK activation.
    Tse AK; Wan CK; Shen XL; Yang M; Fong WF
    Biochem Pharmacol; 2005 Nov; 70(10):1443-57. PubMed ID: 16181613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A honokiol-enriched Magnolia officinalis Rehder & E.H. Wilson. bark extract possesses anxiolytic-like activity with neuroprotective effect through the modulation of CB1 receptor.
    Borgonetti V; Governa P; Manetti F; Miraldi E; Biagi M; Galeotti N
    J Pharm Pharmacol; 2021 Aug; 73(9):1161-1168. PubMed ID: 33950239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The chemopreventive agent oltipraz possesses potent antiangiogenic activity in vitro, ex vivo, and in vivo and inhibits tumor xenograft growth.
    Ruggeri BA; Robinson C; Angeles T; Wilkinson J; Clapper ML
    Clin Cancer Res; 2002 Jan; 8(1):267-74. PubMed ID: 11801568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.